Gilmore Neil O'Neill - Jun 1, 2022 Form 3 Insider Report for Editas Medicine, Inc. (EDIT)

Role
CEO, Director
Signature
/s/ Gilmore O'Neill
Stock symbol
EDIT
Transactions as of
Jun 1, 2022
Transactions value $
$0
Form type
3
Date filed
6/6/2022, 04:43 PM
Previous filing
May 31, 2022
Next filing
Jun 6, 2022

No securities are beneficially owned.